These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 23526674

  • 1. Acute kidney injury during vancomycin therapy in critically ill children.
    Totapally BR, Machado J, Lee H, Paredes A, Raszynski A.
    Pharmacotherapy; 2013 Jun; 33(6):598-602. PubMed ID: 23526674
    [Abstract] [Full Text] [Related]

  • 2. Vancomycin-associated acute kidney injury in pediatric cardiac intensive care patients.
    Moffett BS, Hilvers PS, Dinh K, Arikan AA, Checchia P, Bronicki R.
    Congenit Heart Dis; 2015 Jun; 10(1):E6-10. PubMed ID: 24934335
    [Abstract] [Full Text] [Related]

  • 3. Vancomycin-induced acute kidney injury detected by a prospective pharmacovigilance program from laboratory signals.
    Ramírez E, Jiménez C, Borobia AM, Tong HY, Medrano N, Krauel-Bidwell L, Carcas AJ, Selgas R, Frías J.
    Ther Drug Monit; 2013 Jun; 35(3):360-6. PubMed ID: 23666575
    [Abstract] [Full Text] [Related]

  • 4. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Holsen MR, Meaney CJ, Hassinger AB, Fusco NM.
    Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
    [Abstract] [Full Text] [Related]

  • 5. Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.
    Zappitelli M, Moffett BS, Hyder A, Goldstein SL.
    Nephrol Dial Transplant; 2011 Jan; 26(1):144-50. PubMed ID: 20591815
    [Abstract] [Full Text] [Related]

  • 6. Drug use density in critically ill children and newborns: analysis of various methodologies.
    Valcourt K, Norozian F, Lee H, Raszynski A, Torbati D, Totapally BR.
    Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
    [Abstract] [Full Text] [Related]

  • 7. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ, Cowden C, Laskin BL, Huang YS, Gong W, Bryan M, Fisher BT, Goldstein SL, Zaoutis TE.
    JAMA Pediatr; 2017 Dec 04; 171(12):e173219. PubMed ID: 28973124
    [Abstract] [Full Text] [Related]

  • 8. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA, Smith MN, Painter JT, Meena NK, Lusardi K.
    Pharmacotherapy; 2016 May 04; 36(5):463-71. PubMed ID: 26952639
    [Abstract] [Full Text] [Related]

  • 9. Supratherapeutic vancomycin levels after trauma predict acute kidney injury and mortality.
    Ley EJ, Liou DZ, Singer MB, Mirocha J, Srour M, Bukur M, Margulies DR, Salim A.
    J Surg Res; 2013 Sep 04; 184(1):501-6. PubMed ID: 23731689
    [Abstract] [Full Text] [Related]

  • 10. Nephrotoxicity in patients with vancomycin trough concentrations of 15-20 μg/ml in a pediatric intensive care unit.
    Cies JJ, Shankar V.
    Pharmacotherapy; 2013 Apr 04; 33(4):392-400. PubMed ID: 23471688
    [Abstract] [Full Text] [Related]

  • 11. Identifying High-Risk Medications Associated with Acute Kidney Injury in Critically Ill Patients: A Pharmacoepidemiologic Evaluation.
    Slater MB, Gruneir A, Rochon PA, Howard AW, Koren G, Parshuram CS.
    Paediatr Drugs; 2017 Feb 04; 19(1):59-67. PubMed ID: 27943125
    [Abstract] [Full Text] [Related]

  • 12. Factors associated with acute kidney injury in children receiving vancomycin.
    Sinclair EA, Yenokyan G, McMunn A, Fadrowski JJ, Milstone AM, Lee CK.
    Ann Pharmacother; 2014 Dec 04; 48(12):1555-62. PubMed ID: 25186624
    [Abstract] [Full Text] [Related]

  • 13. Vancomycin-associated acute kidney injury: A cross-sectional study from a single center in China.
    Pan K, Ma L, Xiang Q, Li X, Li H, Zhou Y, Yang L, Cui Y.
    PLoS One; 2017 Dec 04; 12(4):e0175688. PubMed ID: 28426688
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology of acute kidney injury in Canadian critical care units: a prospective cohort study.
    Odutayo A, Adhikari NK, Barton J, Burns KE, Friedrich JO, Klein D, Lapinsky S, Litwin S, Meret A, Moineddin R, Richardson B, Richardson R, Zaltzman A, Hladunewich M, Wald R.
    Can J Anaesth; 2012 Oct 04; 59(10):934-42. PubMed ID: 22843289
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence and risk factors for acute kidney injury associated with parenteral polymyxin B use.
    Mendes CA, Cordeiro JA, Burdmann EA.
    Ann Pharmacother; 2009 Dec 04; 43(12):1948-55. PubMed ID: 19887593
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF, Rigatto MH, Lopes CK, Kamei LK, Rocha JL, Zavascki AP.
    Int J Antimicrob Agents; 2014 Apr 04; 43(4):349-52. PubMed ID: 24439066
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.